The purpose of this study is to examine the safety and efficacy of VSN
A Phase II Proof of Concept (PoC), Double-Blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VSN16R for the Treatment of Spasticity in Subjects with Multiple Sclerosis
What was tested
Treatment tested
- Vsn-16r
What it measured
Main measures
Efficacy analysis by:
Other measures (1)
Modified Ashworth Scale
Spasticity
Papers
Results
Big conductance calcium-activated potassium channel openers control spasticity without sedation.Br J Pharmacol · 2017
Loading reviews and guidelines…
Related trials
- Cryoneurolysis to treat pain in the context of spasticity
Phase 4 · Ongoing (inferred)
Still running
- A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spas
Phase 3 · Not yet recruiting
Still running
- Cannabis (THC vs. CBD) in Multiple Sclerosis
Phase 2 · Recruiting
Still running
- Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pa
Phase 2 · Recruiting
Still running
- Antibiotic strategy and asymptomatic bacteriuria in the context of int
Phase 3 · Ongoing
Still running
- A study to asses the effects of Nabiximols on spasticity associated wi
Phase 3 · Completed
No results found
History
- In scope changed from true to false
Started
Nov 2014
Assembled by software from public sources.